Editorial Policy


The Editorial Policies of the Journal of Medical Practitioners (JMP) reflect our strong commitment to upholding the highest standards of publication ethics and supporting research excellence. These policies are fundamental to our mission as a trustworthy publisher of open access journals to maintain editorial independence and ensure the integrity of our content. We strongly encourage authors to carefully review and adhere to these policies when submitting their manuscripts for consideration.

Authors are advised to consult JMP's Guide for Authors for further guidance and support.

Open Access

JMP publishes articles online, which are free and can be accessed instantly by the reading public upon publication without any hassle.

Learn more about Open Access (OA) at Logixs Journals.

Authorship Criteria

JMP adheres to the guidelines set forth by the International Committee of Medical Journal Editors (ICMJE) regarding authorship criteria. To be listed as a contributing author, one must have made a significant contribution to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work. In addition, the author should have drafted or revised the work critically for important intellectual content, approved the final draft for publication, and agreed to be held accountable for all aspects of the work. If an author fails to meet these criteria, they should be listed in the acknowledgment section.

JMP requires all potential authors to provide a contributorship statement, using the roles defined by the CRediT taxonomy, for all articles. Please note that the contributor roles may vary for different types of articles. All authors are required to report their contributions in the following format:

Author AA Contributor Role 1
Author BB Contributor Role 2, Contributor Role 3
Author CC Contributor Role 4, Contributor Role 5

We encourage all authors to provide an ORCID ID.

Changes to Authorship

JMP expects authors to ensure the accuracy of authorship information before submitting a manuscript. If any authorship changes are required, authors should complete the Change of Authorship Form according to the provided guidelines. All contributing authors must sign the form before submitting it to the editorial office. Authorship changes must be requested before the article is accepted, as the journal cannot accommodate such requests after acceptance.

Conflicts of Interest

JMP requires all contributing authors to disclose any potential conflicts of interest related to their scholarly work on the title page of their manuscript. This declaration should include both financial and non-financial conflicts. If authors have no conflicts of interest, they must include the following statement:

Conflict of Interest: The author(s) declare(s) no conflicts of interest.

Manuscripts with declared conflicts of interest will be evaluated transparently and may not necessarily be rejected.

In addition, board members and reviewers must also disclose any conflicts of interest they may have. If a conflict of interest exists, they will be excluded from handling that particular manuscript during the editorial and peer-review process.

According to the Committee on Publication Ethics (COPE), a conflict of interest occurs when a person or organization is involved in multiple interests, including financial interests, which could potentially corrupt their motivations. The presence of a conflict of interest is not dependent on any actual impropriety.

We encourage authors to consult the following resources to gain a better understanding of conflicts of interest:

Cope Guidelines on Good Publication Practice

The ICMJE Guidelines


JMP adheres to COPES Ethical Guidelines for Peer Reviewers. It is the responsibility of the reviewers to maintain the confidentiality of the peer-review process by safeguarding the content of a manuscript, including the review report.


JMP expects authors to avoid any misconduct related to citations, such as using self-citation excessively or making improper prearrangements among author groups to manipulate citation metrics. This practice is known as citation manipulation, and it is not acceptable. For more information, please refer to the COPE Guidance Relating to Citation Manipulation.

Authors should always cite relevant and appropriate literature to support their claims in all types of articles, including original research and non-research articles, such as viewpoints. The journal will reject manuscripts that contain citation manipulation.


JMP maintains a rigorous policy against plagiarism to ensure the highest standards of academic integrity. Any instances of plagiarism will be dealt with in accordance with the COPE Guidelines. We reserve the right to reject manuscripts during the editorial or peer review process, impose sanctions on authors, and retract published articles that contain plagiarized content.

For JMP, plagiarism is defined as the use of data, words, text, or illustrations from electronic or printed sources without proper attribution to the original work. We require all authors to cite the original source of any material they use in their manuscripts to avoid any potential issues of plagiarism.

We expect all authors to uphold the highest standards of academic integrity when submitting their work to JMP. By submitting their manuscript, authors agree to comply with our policy against plagiarism.

Duplicate Submission

JMP only considers submissions that have not been published before and are not under review by any other journals. We allow authors to submit their work that is based on their thesis or preprint servers. Authors who submit duplicate manuscripts to JMP or any other journal will be rejected.

Salami-slicing, or the attempt to publish multiple articles with similar content, is strongly discouraged. Manuscripts found to be very similar to previously published work will be rejected during the editorial and peer-review process. If such an article is published, it will be retracted.

Data Integrity

JMP is committed to maintaining the highest standards of data integrity. Data falsification involves manipulating research data with the intention of providing a false impression. Examples of data falsification include, but are not limited to, eliminating data outliers, manipulating illustrations, altering problematic results, and adding, omitting, or changing data sets. Data fabrication involves creating research findings that do not exist.

To ensure the integrity of the research published in JMP, we may request that authors provide the original research data for verification purposes. Failure to provide the research data may result in the rejection of the manuscript during the editorial and peer-review process and retraction of the published article.

Ethics and Consent

Authors must adhere to the principles outlined in the Declaration of Helsinki when conducting research involving human subjects, materials, or data and obtain approval from the appropriate ethics review committee. The manuscript must include the name of the ethics review committee and its reference number, except for those studies exempt from ethics approval, along with the reason for such exemption and the name of the body granting it, if applicable.

JMP does not accept manuscripts lacking an appropriate ethical framework, and retrospective ethics approval is not considered.

In supplement to the ethics approval, authors should obtain informed consent from study participants who are human subjects. For minor participants, informed consent should be obtained from their parent or guardian. This information should also be included in the manuscript.

If the manuscript involves vulnerable groups, potential coercion, or insufficiently informed consent, the editorial office will scrutinize it carefully, and authors may be asked to provide documentary evidence before it is considered for publication.

Cell Line Policy

Authors conducting research with cell lines should provide information about the origin of the cell lines used in the methods section of their manuscript. Proper attribution and references should be given to any previously published research or commercial sources for established cell lines. If the study has generated de novo cell lines, which may include those gifted from another laboratory, authors must obtain ethical clearance from the appropriate ethics review committee. If the cell line is of human origin, written informed consent must also be provided.

Plant Research Policy

Authors must comply with national and international guidelines when conducting experimental studies on plants, including collecting plant material, and must obtain ethical clearance from the appropriate ethics review committee.

In the methods section of the manuscript, authors should provide the genetic information and origin of the plants used. Voucher specimens of rare plants should be deposited in an accessible museum or herbarium, including information on populations sampled, collection date, and parts used.

Additionally, authors must read and comply with the following policies:

IUCN Policy Statement on Research Involving Species at Risk of Extinction

Convention on the Trade in Endangered Species of Wild Fauna and Flora

Animal Research Policy

Research involving animals is the responsibility of the author(s), who must ensure that every experimental study complies with national and international relevant guidelines and has received ethical clearance from the appropriate ethics review committee.

We require authors to read and follow:

Basel Declaration

Ethical Guidelines of the International Council for Laboratory Animal Science

Authors must include a statement describing their compliance with the appropriate guidelines for conducting the study, as well as disclose information about the ethical approval accompanying the study approval number and the name of the ethics review committee. If a study is exempt from requiring ethics approval, the authors must state the details of the body granting exemption and the reason for such exemption.

Authors must obtain informed consent from those who keep animals, adhering to the best veterinary care practices when recruiting animals for experimental studies.

Non-experimental studies and field surveys must also comply with national and international relevant guidelines and obtain ethical clearance from the appropriate ethics review committee. Authors must include a statement describing their compliance with the appropriate guidelines for conducting the study, as well as disclose information about the ethical approval accompanying the study approval number and the name of the ethics review committee.

We require authors to read and follow:

IUCN Policy Statement on Research Involving Species at Risk of Extinction

Convention on the Trade in Endangered Species of Wild Fauna and Flora

The authors should also refer to the following resources:

The Principles of 3Rs

Code of Practice for the Housing and Care of Animals Bred, Supplied or Used for Scientific Purposes

The Scientific Basis for Regulation of Animal Care and Use

EU Regulations on Animal Research

Trial Registration

JMP adheres to the ICMJE Guidelines and requires authors to register their clinical trials in a public trials registry before enrolling the first subject. The trial registration number and date must be cited in the manuscript. We recommend that authors select an appropriate international clinical trial register from the following resources:

Primary Registries in the WHO Registry Network

Clinical Trials Registration

Manuscripts will not be processed for peer review without trial registration. However, if the study protocol has been published before the first subject enrollment, such submissions may be considered without registration only if the authors have appropriately cited the published protocol.

Reporting Guidelines

We require authors to adopt appropriate reporting guidelines while preparing manuscripts for the JMP to ensure the maximization of transparency and reproducibility. We particularly encourage the use of the following reporting guidelines:

AGREE Clinical Practice Guidelines
ARRIVE Animal Experiments
CARE Case Reports
CHEERS Economics Evaluations
CONSORT Randomized Controlled Trials
PRISMA Systematic Review and Meta-Analyses
 SQUIRE Quality Improvement Studies 
 STARD  Diagnostic Accuracy Studies
SRQR Qualitative Studies
STREGA Genetic Association Studies
STROBE Observational Studies
TREND Non-Randomized Trials

Sex and Gender

JMP recognizes the importance of sex and gender in research and encourages authors to use the terms 'sex' for biological attributes and 'gender,' where the variable is formed through social and cultural factors. To ensure the appropriate consideration of sex and gender in research, authors should read the full guidelines of Sex and Gender Equity in Research SAGER before submission. The SAGER guidelines provide a framework for reporting sex and gender information in research studies and aim to improve transparency, accuracy, and inclusivity in research.

Peer Review

JMP follows the double-anonymous peer review model, where the identities of both the reviewers and the authors are kept confidential. This model is designed to ensure a fair and unbiased review process that is focused solely on the quality of the manuscript.

We consider the assessment of the manuscript complete only if comments from a minimum of two independent experts are received. Reviewers are selected based on their expertise and their ability to provide a thorough and constructive evaluation of the manuscript. They are expected to provide feedback on the scientific content, methodology, and interpretation of the results, as well as any ethical or legal concerns.

JMP strives to provide a timely and efficient peer review process, and we ask reviewers to submit their comments within a reasonable timeframe. In cases where conflicting reviews are received, we may seek additional opinions or request that the authors revise the manuscript to address any concerns raised by the reviewers.

We value the time and effort that our reviewers put into the peer review process and recognize their critical role in ensuring the quality of the manuscripts we publish. We also encourage authors to carefully consider and respond to the feedback provided by the reviewers, as this can help to improve the quality and impact of their work.

Jurisdictional Claims

Logixs Journals and JMP do not take any stance or position on jurisdictional claims related to the subject matter of the articles they publish, including maps and institutional affiliations.

Data Sharing

We encourage authors to share the datasets by depositing them in publicly available repositories or submitting them as supplementary files (in a machine-readable format such as XLS, XLSX etc.) with the manuscript upon which the manuscript is constructed. If the manuscript is accepted for publication in JMP, supplementary dataset file(s) will be published in the HTML version, which will be freely available to the public for non-commercial use by maintaining the confidentiality of the participants. All authors must provide a statement in the manuscript regarding data availability (see the section: instructions for authors by accessing the specific journal's homepage). Authors who do not wish to share the data must state the reason for not doing so.

Corrections & Retractions

Ensuring the integrity of the academic record is of utmost importance to us. In the event that errors are discovered in a published article, we will take appropriate action to address the issue.

For errors related to authorship, we may publish a corrigendum. For errors related to the publisher, we may publish an erratum. These corrections will be made available on the journal's website and indexed appropriately.

In cases where errors significantly affect the conclusions or raise concerns about research misconduct, we may retract the article. Retraction may also be appropriate if there are ethical issues with the research or concerns about the reliability of the data.

Logixs Journals follows the COPE Retraction Guidelines. We take this process seriously and will ensure that any retraction is done in a transparent and responsible manner.

Appeals & Complaints

If readers have complaints or concerns regarding published articles, they should first contact the authors directly for resolution or clarification. If the issue persists or the corresponding author is unresponsive, the reader may contact the JMP editorial office. The journal handles complaints or appeals related to legal aspects, validity concerns, and research integrity of published papers or the review process.

The JMP editor-in-chief investigates such complaints and makes a final decision in consultation with the journal's editorial board, which may include corrections, retractions, or other measures. Complaints regarding research integrity are addressed in accordance with COPE Guidelines.

All complaints and appeals are handled confidentially, and the complainant should understand that investigations take time to conduct. JMP only accepts complaints and appeals submitted through the e-Complaint/Appeal Form available on our website. Complaints and appeals containing incorrect or non-verifiable information will be discarded.

If the grievance is found to be non-verifiable, the complainant will not be informed of the outcome.